Maria E. Powell

Maria E. Powell

Auto-generated profile, based on publicly available information

Maria E. Powell

Vanderbilt University Medical Center Nashville TN USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Journal of Voice
Verified
Journal Article
Closed access
MPMaria E. Powell
Maria E. Powell
DDDimitar D. Deliyski
Dimitar D. Deliyski
SZSteven M. Zeitels
Steven M. Zeitels
JBJames A. Burns
James A. Burns
RHRobert E. Hillman
Robert E. Hillman
DMDaryush D. Mehta
Daryush D. Mehta

25 March 2019 in Laryngoscope Investigative Otolaryngology
Verified
Journal Article
Open access
PDF file
MPMaria E. Powell
Maria E. Powell
MCMarcelino Rodriguez Cancio
Marcelino Rodriguez Cancio
DYDavid YOUNG
David YOUNG
WNWilliam Nock
William Nock
BABeshoy Abdelmessih
Beshoy Abdelmessih
AGAlexander Gelbard
Alexander Gelbard
Objective: Acoustic analysis of voice has the potential to expedite detection and diagnosis of voice disorders. Applying an image‐based, neural‐network approach to analyzing the acoustic signal may be an effective means for detecting and differentially diagnosing voice disorders. The purpose of this study is to provide a proof‐of‐concept that embedded data within human phonation can be accurately and efficiently decoded with deep learning neural network analysis to differentiate between normal and disordered voices.Methods: Acoustic recordings from 10 vocally‐healthy speakers, as well as 70 patients with one of seven voice disorders (n = 10 per diagnosis), were acquired from a clinical database. Acoustic signals were converted into spectrograms and used to train a convolutional neural network developed with the Keras library. The network architecture was trained separately for each of the seven diagnostic categories. Binary classification tasks (ie, to classify normal vs. disordered) were performed for each of the seven diagnostic categories. All models were validated using the 10‐fold cross‐validation technique.Results: Binary classification averaged accuracies ranged from 58% to 90%. Models were most accurate in their classification of adductor spasmodic dysphonia, unilateral vocal fold paralysis, vocal fold polyp, polypoid corditis, and recurrent respiratory papillomatosis. Despite a small sample size, these findings are consistent with previously published data utilizing deep neural networks for classification of voice disorders.Conclusion: Promising preliminary results support further study of deep neural networks for clinical detection and diagnosis of human voice disorders. Current models should be optimized with a larger sample size.Levels of Evidence: Level III

1 June 2024 in Otolaryngology–Head and Neck Surgery
Verified
Journal Article
Closed access
EEEmily G. Evangelista
Emily G. Evangelista
JBJean‐Christophe Bélisle‐Pipon
Jean‐Christophe Bélisle‐Pipon
MNMatthew R. Naunheim
Matthew R. Naunheim
MPMaria Powell
Maria Powell
HGHortense Gallois
Hortense Gallois
YBYael Bensoussan
Yael Bensoussan

13 December 2023 in The Laryngoscope
Verified
Journal Article
Closed access
EEEmily Evangelista
Emily Evangelista
RKRohan Kale
Rohan Kale
DMDesiree McCutcheon
Desiree McCutcheon
ARAnaïs Rameau
Anaïs Rameau
AGAlexander Gelbard
Alexander Gelbard
YBYael Bensoussan
Yael Bensoussan

29 September 2023 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
YYYu Yao
Yu Yao
MPMaria Powell
Maria Powell
JWJules White
Jules White
JFJian Feng
Jian Feng
QFQuchen Fu
Quchen Fu
DSDouglas C. Schmidt
Douglas C. Schmidt

19 September 2022 in Laryngoscope Investigative Otolaryngology
Verified
Journal Article
Open access
ASAmy Stone
Amy Stone
MPMaria E. Powell
Maria E. Powell
KHKaitlyn Hamers
Kaitlyn Hamers
KFK. Charles Fletcher
K. Charles Fletcher
DFDavid O. Francis
David O. Francis
CGC. Gaelyn Garrett
C. Gaelyn Garrett
Objective: The purpose of this study was to quantitatively compare the effectiveness of unilateral and bilateral botulinum toxin A (BTX‐A) injections for mitigating undesirable weak/breathy voice quality and dysphagia for patients with adductor spasmodic dysphonia and/or essential tremor of voice (ETV).Methods: Data were collected from the medical records of 319 patients, yielding three treatment cohorts: patients who received an equal dose bilateral injection regimen (BL=) throughout their course of treatment at VUMC, patients who switched to a unilateral injection regimen (UL), and patients who switched to an unequal dose bilateral injection regimen (BL≠). Changes in length of improvement, duration of weak/breathy voice, and dysphagia severity were compared.Results: The BL = treatment group reported the longest duration of improved voice. Shorter periods of improved voice were reported at baseline by patients who later switched to UL or BL ≠ injection regimens. Patients receiving UL injections reported significantly reduced weak/breathy voice and dysphagia. Patients receiving BL ≠ injections reported increased length of improved voice; however, dysphagia symptoms increased. Ninety‐two percent of patients with ETV switched to a UL regimen, with 61% of patients transitioning within the first three injections.Conclusions: Patients with pronounced dysphagia and extended periods of weak/breathy voice may benefit from a UL injection approach to mitigate side effects from BTX‐A without sacrificing improved voice outcomes. For patients seeking to extend their length of improved voice, a BL ≠ injection regimen may be effective provided the adverse side effects from BTX‐A are minimal. Patients with ETV may benefit from a UL injection approach at the outset of their course of treatment with BTX‐A.Level of evidence: III.